SLC30A8 and type 2 diabetes mellitus: A number of studies of patients with type 2 diabetes (T2D) from different populations have confirmed an association between a nonsynonymous polymorphism in SLC30A8, which encodes ZnT8, and elevated disease risk (3–11).